Paul Muhler
Papers
1
Total Citations
3
H-Index
1
About
Paul Muhler is a health economist and outcomes researcher whose work focuses on the economic evaluation of novel medical technologies, particularly in the field of oncology. His key research areas include cost-effectiveness analysis, health technology assessment, and the economic impact of minimally invasive treatments for prostate cancer. Muhler’s major contribution is his pioneering cost–utility analysis of magnetic resonance imaging-guided transurethral ultrasound ablation (MR-TULSA) for low- to intermediate-risk localized prostate cancer, a study that provides critical evidence for the technology’s value compared to established treatments. This work, published in 2025, has already garnered 3 citations, signaling its early influence on clinical and policy decision-making. By demonstrating that MR-TULSA offers a favorable balance of costs and quality-adjusted life years, Muhler’s research supports the large-scale implementation of a therapy that reduces adverse effects. His rigorous economic modeling helps bridge the gap between innovation and real-world adoption, making him a key voice in the growing field of focal therapy evaluation.
Research Focus
Key Achievements
Top Papers
- 1